{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:28:59Z","timestamp":1789810139091,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nucmedbio.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T15:18:22Z","timestamp":1489850302000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Contribution of neuroinflammation to changes in [ 11 C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6820-9474","authenticated-orcid":false,"given":"Andrea","family":"Parente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3308-3167","authenticated-orcid":false,"given":"David","family":"V\u00e1llez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora","family":"Lopes Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Zijlma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi AJO","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Buchpiguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik FJ","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.nucmedbio.2017.03.001_bb0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"GABA, gamma-hydroxybutyric acid, and neurological disease","volume":"54","author":"Wong","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0010","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0883-2889(88)90044-5","article-title":"11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors","volume":"39","author":"Halldin","year":"1988","journal-title":"Int J Rad Appl Instrum A"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuroimage.2008.12.005","article-title":"[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil","volume":"45","author":"Odano","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1161\/01.STR.0000134746.93535.9b","article-title":"Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography\/magnetic resonance imaging study in early ischemic stroke","volume":"35","author":"Heiss","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12149-011-0480-4","article-title":"Validation of reference tissue modelling for [11C]flumazenil positron emission tomography following head injury","volume":"25","author":"Geeraerts","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0030","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/WNL.54.12.2252","article-title":"[11 C]flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology","volume":"54","author":"Lamusuo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/brain\/aws210","article-title":"Decreased carbon-11-flumazenil binding in early Alzheimer's disease","volume":"135","author":"Pascual","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.STR.29.2.454","article-title":"Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke","volume":"29","author":"Heiss","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.STR.31.2.366","article-title":"Early [(11)C]flumazenil\/H(2)O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy","volume":"31","author":"Heiss","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2015.00172","article-title":"Immune aging, dysmetabolism, and inflammation in neurological diseases","volume":"9","author":"Deleidi","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases - an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0065","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1007\/s11064-012-0808-z","article-title":"Astrocytes as GABA-ergic and GABA-ceptive cells","volume":"37","author":"Yoon","year":"2012","journal-title":"Neurochem Res"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1113\/jphysiol.2008.163923","article-title":"GABAergic activities enhance macrophage inflammatory protein-1alpha release from microglia (brain macrophages) in postnatal mouse brain","volume":"587","author":"Cheung","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","article-title":"GABA, a natural immunomodulator of T lymphocytes","volume":"205","author":"Bjurst\u00f6m","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.1203604","article-title":"Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy","volume":"78","author":"Stuckey","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/apha.12467","article-title":"GABAergic signalling in the immune system","volume":"213","author":"Barragan","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","article-title":"GABA is an effective immunomodulatory molecule","volume":"45","author":"Jin","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/08916934.2011.571223","article-title":"Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis","volume":"44","author":"Tian","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0105","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","article-title":"Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model","volume":"173","author":"Tian","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0110","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/jcbfm.1995.34","article-title":"Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol","volume":"15","author":"Delforge","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/jcbfm.1995.17","article-title":"Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle","volume":"15","author":"Lassen","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/jcbfm.1994.45","article-title":"Saturation analysis in PET--analysis of errors due to imperfect reference regions","volume":"14","author":"Litton","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.jcbfm.9600554","article-title":"Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies","volume":"28","author":"Klumpers","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2967\/jnumed.115.165019","article-title":"Pharmacokinetic analysis of 11C-PBR28 in the rat model of herpes encephalitis: comparison with (R)-11C-PK11195","volume":"57","author":"Parente","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11307-009-0211-6","article-title":"[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis","volume":"11","author":"Doorduin","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00259-015-3021-x","article-title":"Evaluation of [(11)C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis","volume":"42","author":"V\u00e1llez Garc\u00eda","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/(SICI)1099-1344(1998090)41:9<831::AID-JLCR129>3.0.CO;2-E","article-title":"Methylation of amide and thiol functions with [11C]methyl triflate, as exemplified by [11C]NMSP[11C]flumazenil and [11C]methionine","volume":"41","author":"N\u00e5gren","year":"1998","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s00259-009-1066-4","article-title":"In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat","volume":"36","author":"Dedeurwaerdere","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122363","article-title":"A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox","volume":"10","author":"V\u00e1llez Garc\u00eda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0170","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0175","series-title":"Generalized estimating equations","author":"Hardin","year":"2012"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.jcbfm.9600515","article-title":"[11C]flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling?","volume":"28","author":"Hammers","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nucmedbio.2009.09.002","article-title":"Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis","volume":"37","author":"Doorduin","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0195","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.115.165019","article-title":"Pharmacokinetic analysis of 11C-PBR28 in the rat model of herpes encephalitis (HSE): comparison with (R)-11C-PK11195","author":"Parente","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/38614","article-title":"Inhibitory synapses. Anaesthetics set their sites on ion channels","volume":"389","author":"Franks","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00000542-199101000-00016","article-title":"The influence of inhalational anesthetics on in vivo and in vitro benzodiazepine receptor binding in the rat cerebral cortex","volume":"74","author":"Hansen","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0210","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s000180050371","article-title":"General anaesthetic actions on ligand-gated ion channels","volume":"55","author":"Krasowski","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000542-200109000-00008","article-title":"Dose-dependent enhancement of in vivo GABA(a)-benzodiazepine receptor binding by isoflurane","volume":"95","author":"Gyulai","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13550-016-0235-2","article-title":"Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor","volume":"6","author":"Palner","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0225","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1006\/nimg.2002.1233","article-title":"Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters","volume":"17","author":"Millet","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0306-4522(88)90036-X","article-title":"Benzodiazepine receptor sites in the human brain: autoradiographic mapping","volume":"25","author":"Zezula","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.nucmedbio.2017.03.001_bb0235","first-page":"228","article-title":"SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms","volume":"35","author":"Abi-Dargham","year":"1994","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116304152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116304152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:28:23Z","timestamp":1535959703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805116304152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":46,"alternative-id":["S0969805116304152"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.03.001","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of neuroinflammation to changes in [11C]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}